Stockreport

Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Intrinsic Value Is Potentially 99% Above Its Share Price [Yahoo! Finance]

Ligand Pharmaceuticals Incorporated  (LGND) 
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.ligand.com
PDF Analyst price target for LGND is US$133 which is 49% below our fair value estimate Today we will run through one way of estimating the intrinsic value of Ligand Pharm [Read more]